BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer ...

Therapeutics reports preclinical data showing strong anti-cancer activity of its next generation, personalized, off-the-shelf, ...

Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced a significant milestone for both Theragent and its sponsor client, CellVax ...

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

Global poultry vaccine market is observing significant growth owing to the rising prevalence of poultry diseases. The report runs an in-dept ...

Androgen-deprivation therapy (ADT) plus vaccine: ADT has been shown to potentiate immune responses and mitigate immune tolerance to prostate cancer antigens. Chemotherapy plus vaccine: Certain ...

AN orange zombie fungus that sprouts from the backs of caterpillars could be used to fight cancer, new research suggests. Scientists have found the fungus, called Cordyceps, works by stopping cell ...

Among major accomplishments are her contribution to R&D and translation effort for the production of technetium-99m with cyclotron, and implementation of investigational prostate cancer ...

One study believes that 1.2 million lung cancer deaths could be prevented in 70 years just by banning tobacco products for ...

Medical experts have called for more health-care resources and education targeting women, children and the elderly during the ...

Tumor Suppressor Protein Par-4 Triggers Unique Cell Death Pathway in Cancerous Cells July 23, 2024 — A team of researchers has discovered that the tumor suppressor protein Prostate apoptosis ...

The World Health Organization and a coalition of partners have allocated 899,000 vaccine doses for nine countries in ... is ...